• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
EDIT

EDIT

Editas Medicine, Inc.

NASDAQHealthcareBiotechnologyUS

USD2.78

-0.04 (-1.42%)

Rating:C-

Company Profile

CEO

Gilmore O'Neill

IPO Date

2016-02-03

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$2.81

Prev. Close

$2.82

Day Low

$2.63

Day High

$2.91

52W Low

$1.66

52W High

$4.54

Market Cap

$0.27B

Volume

3.19M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

29.8%

Avg Negative

14.0%

Avg Neutral

56.2%

News Feed

Editas: Gene Therapy Specialist Leading The Way In Eye Disease

Seeking Alpha·8/27/2021·↑ positive

Editas Medicine Unveils Preclinical Data From New Gene Editing Technology

Benzinga·8/23/2021·↑ positive

Editas Medicine Presents Data on New SLEEK Gene Editing Technology at Cold Spring Harbor Laboratory's Genome Engineering: CRISPR Frontiers Meeting

GlobeNewsWire
·8/20/2021
·↑ positive

Why Editas Medicine Beat the Market on Monday

The Motley Fool·8/9/2021·↑ positive

Editas (EDIT) Q2 Earnings Beat Estimates, Revenues Fall Y/Y

Zacks Investment Research·8/5/2021·↓ negative

Editas Medicine, Inc. (EDIT) CEO Jim Mullen on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha·8/4/2021·↓ negative

Editas Medicine (EDIT) Reports Q2 Loss, Misses Revenue Estimates

Zacks Investment Research·8/4/2021·↑ positive

Editas Medicine (EDIT) Stock Moves -0.1%: What You Should Know

Zacks Investment Research·7/30/2021·↑ positive

Editas Medicine and IDT Announce Publication in Nature Communications of Research Data Supporting the Use of Optimized AsCas12a Nuclease Variant, Alt-R A.s. Cas12a (Cpf1) Ultra, in Researching the Potential of Gene-Edited Cell Medicines

GlobeNewsWire·7/29/2021·↑ positive

Editas Medicine Names Bruce E. Eaton, Ph.D.

GlobeNewsWire·7/26/2021·↑ positive